Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission.

Stubbs MJ, Thomas M, Vendramin C, Sonesson E, Kjellman C, Järnum S, Stenberg Y, Elfving C, Scully M.

Br J Haematol. 2019 Jul;186(1):137-140. doi: 10.1111/bjh.15706. Epub 2018 Nov 29. No abstract available.

PMID:
30488420
2.

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

Lorant T, Bengtsson M, Eich T, Eriksson BM, Winstedt L, Järnum S, Stenberg Y, Robertson AK, Mosén K, Björck L, Bäckman L, Larsson E, Wood K, Tufveson G, Kjellman C.

Am J Transplant. 2018 Nov;18(11):2752-2762. doi: 10.1111/ajt.14733. Epub 2018 Apr 17.

3.

Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS.

Karlsson CAQ, Järnum S, Winstedt L, Kjellman C, Björck L, Linder A, Malmström JA.

Mol Cell Proteomics. 2018 Jun;17(6):1097-1111. doi: 10.1074/mcp.RA117.000525. Epub 2018 Mar 6.

4.

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.

Jordan SC, Lorant T, Choi J, Kjellman C, Winstedt L, Bengtsson M, Zhang X, Eich T, Toyoda M, Eriksson BM, Ge S, Peng A, Järnum S, Wood KJ, Lundgren T, Wennberg L, Bäckman L, Larsson E, Villicana R, Kahwaji J, Louie S, Kang A, Haas M, Nast C, Vo A, Tufveson G.

N Engl J Med. 2017 Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. Erratum in: N Engl J Med. 2017 Oct 26;377(17 ):1700.

5.

Enzymatic Inactivation of Endogenous IgG by IdeS Enhances Therapeutic Antibody Efficacy.

Järnum S, Runström A, Bockermann R, Winstedt L, Crispin M, Kjellman C.

Mol Cancer Ther. 2017 Sep;16(9):1887-1897. doi: 10.1158/1535-7163.MCT-17-0108. Epub 2017 May 22.

6.

IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barré syndrome.

Wang Y, Shi Q, Lv H, Hu M, Wang W, Wang Q, Qiao B, Zhang G, Lv Z, Kjellman C, Järnum S, Winstedt L, Zhang Y, Wen J, Hao Y, Yuki N.

Exp Neurol. 2017 May;291:134-140. doi: 10.1016/j.expneurol.2017.02.010. Epub 2017 Feb 16.

PMID:
28214515
7.

HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.

Safavi S, Järnum S, Vannas C, Udhane S, Jonasson E, Tomic TT, Grundevik P, Fagman H, Hansson M, Kalender Z, Jauhiainen A, Dolatabadi S, Stratford EW, Myklebost O, Eriksson M, Stenman G, Schneider-Stock R, Ståhlberg A, Åman P.

Oncotarget. 2016 Jan 5;7(1):433-45. doi: 10.18632/oncotarget.6336.

8.

The Bacterial Enzyme IdeS Cleaves the IgG-Type of B Cell Receptor (BCR), Abolishes BCR-Mediated Cell Signaling, and Inhibits Memory B Cell Activation.

Järnum S, Bockermann R, Runström A, Winstedt L, Kjellman C.

J Immunol. 2015 Dec 15;195(12):5592-601. doi: 10.4049/jimmunol.1501929. Epub 2015 Nov 9.

9.

Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic Opportunity.

Winstedt L, Järnum S, Nordahl EA, Olsson A, Runström A, Bockermann R, Karlsson C, Malmström J, Palmgren GS, Malmqvist U, Björck L, Kjellman C.

PLoS One. 2015 Jul 15;10(7):e0132011. doi: 10.1371/journal.pone.0132011. eCollection 2015.

10.

Alpha10 integrin expression is up-regulated on fibroblast growth factor-2-treated mesenchymal stem cells with improved chondrogenic differentiation potential.

Varas L, Ohlsson LB, Honeth G, Olsson A, Bengtsson T, Wiberg C, Bockermann R, Järnum S, Richter J, Pennington D, Johnstone B, Lundgren-Akerlund E, Kjellman C.

Stem Cells Dev. 2007 Dec;16(6):965-78.

PMID:
18047418
11.
12.

The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.

Engström K, Willén H, Kåbjörn-Gustafsson C, Andersson C, Olsson M, Göransson M, Järnum S, Olofsson A, Warnhammar E, Aman P.

Am J Pathol. 2006 May;168(5):1642-53.

13.

Oncostatin M signaling in human glioma cell lines.

Krona A, Järnum S, Salford LG, Widegren B, Aman P.

Oncol Rep. 2005 May;13(5):807-11.

PMID:
15809742
14.

LEPREL1, a novel ER and Golgi resident member of the Leprecan family.

Järnum S, Kjellman C, Darabi A, Nilsson I, Edvardsen K, Aman P.

Biochem Biophys Res Commun. 2004 Apr 30;317(2):342-51.

PMID:
15063763
15.

Identification and characterization of a human smad3 splicing variant lacking part of the linker region.

Kjellman C, Honeth G, Järnum S, Lindvall M, Darabi A, Nilsson I, Edvardsen K, Salford LG, Widegren B.

Gene. 2004 Mar 3;327(2):141-52.

PMID:
14980711
16.

Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections.

Staun M, Tjellesen L, Thale M, Schaadt O, Jarnum S.

Scand J Gastroenterol. 1997 Mar;32(3):226-32.

PMID:
9085459
17.

The metabolism of [75Se]selenite in patients with short bowel syndrome.

Rannem T, Hylander E, Ladefoged K, Staun M, Tjellesen L, Jarnum S.

JPEN J Parenter Enteral Nutr. 1996 Nov-Dec;20(6):412-6.

PMID:
8950742
18.

Body composition in patients on home parenteral nutrition.

Tjellesen L, Staun M, Rannem T, Nielsen PK, Jarnum S.

Scand J Clin Lab Invest. 1996 Jul;56(4):295-303.

PMID:
8837235
19.

Nutrition in short-bowel syndrome.

Ladefoged K, Hessov I, Jarnum S.

Scand J Gastroenterol Suppl. 1996;216:122-31. Review.

PMID:
8726285
20.

Bone mineral content in patients on home parenteral nutrition.

Staun M, Tjellesen L, Thale M, Rannem T, Schaadt O, Jarnum S.

Clin Nutr. 1994 Dec;13(6):351-5.

PMID:
16843413
21.

Postoperative electrolyte and mineral balance after restorative proctocolectomy with ileoanal reservoir.

Hansen CP, Kirkegaard P, Hjortrup A, Jarnum S.

Dan Med Bull. 1994 Sep;41(4):472-4.

PMID:
7813255
22.

[Chronic radiation enteropathy. A retrospective study].

Kryger-Baggesen N, Moldow B, Rasmussen G, Dissing I, Møller EH, Ladefoged K, Jarnum S.

Ugeskr Laeger. 1993 Dec 20;155(51):4180-4. Danish.

PMID:
8273244
23.

Selenium depletion in patients on home parenteral nutrition. The effect of selenium supplementation.

Rannem T, Ladefoged K, Hylander E, Hegnhøj J, Jarnum S.

Biol Trace Elem Res. 1993 Oct;39(1):81-90.

PMID:
7505102
24.

Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals.

Friis S, Dabelsteen E, Sjöström H, Norén O, Jarnum S.

Gut. 1992 Nov;33(11):1487-92.

25.

Selenium status in patients with Crohn's disease.

Rannem T, Ladefoged K, Hylander E, Hegnhøj J, Jarnum S.

Am J Clin Nutr. 1992 Nov;56(5):933-7.

PMID:
1415013
26.

Fate of the rectum after colectomy and ileostomy for Crohn's colitis.

Harling H, Hegnhøj J, Rasmussen TN, Jarnum S.

Dis Colon Rectum. 1991 Oct;34(10):931-5.

PMID:
1914729
27.

Different disinfectants for catheter-related sepsis in long term parental nutrition with Broviac catheters.

Rannem T, Ladefoged K, Hegnhøj J, Hylander Møller E, Brunn B, Jarnum S.

Clin Nutr. 1991 Feb;10(1):60. No abstract available.

PMID:
16839896
28.

Absorption studies after ileal J-pouch anastomosis for ulcerative colitis. A prospective study.

Hylander E, Rannem T, Hegnhøj J, Kirkegaard P, Thale M, Jarnum S.

Scand J Gastroenterol. 1991 Jan;26(1):65-72.

PMID:
2006400
29.

Calcium absorption and bone mineral content in patients subjected to ileal bypass because of familial hypercholesterolaemia.

Rannem T, Hylander E, Jarnum S, Ladefoged K, Schaadt O, Staun M, Thale M.

Scand J Gastroenterol. 1990 Sep;25(9):897-905.

PMID:
2218396
30.

Calcium absorption after intestinal resection. The importance of a preserved colon.

Hylander E, Ladefoged K, Jarnum S.

Scand J Gastroenterol. 1990 Jul;25(7):705-10.

PMID:
2396084
31.

Catheter-related sepsis in long-term parenteral nutrition with Broviac catheters. An evaluation of different disinfectants.

Rannem T, Ladefoged K, Hegnhøj J, Møller EH, Bruun B, Jarnum S.

Clin Nutr. 1990 Jun;9(3):131-6.

PMID:
16837344
32.

Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III.

Malchow H, Steinhardt HJ, Lorenz-Meyer H, Strohm WD, Rasmussen S, Sommer H, Jarnum S, Brandes JW, Leonhardt H, Ewe K, et al.

Scand J Gastroenterol. 1990 Mar;25(3):235-44.

PMID:
1969678
33.

Ulcerative colitis and Crohn's disease of the colon. Is there a macroscopic difference?

Palnaes Hansen C, Hegnhøj J, Møller A, Brauer C, Hage E, Jarnum S.

Ann Chir Gynaecol. 1990;79(2):78-81.

PMID:
2386361
34.
35.

Malignancy in ulcerative colitis.

Kvist N, Jacobsen O, Kvist HK, Nørgaard P, Ockelmann HH, Schou G, Jarnum S.

Scand J Gastroenterol. 1989 May;24(4):497-506.

PMID:
2781242
37.

[Social conditions and quality of life of patients receiving prolonged parenteral nutrition in their homes. A questionnaire study].

Goldstein V, Ladefoged K, Goldstein H, Hegnhøj J, Jarnum S.

Ugeskr Laeger. 1988 Jun 20;150(25):1534-7. Danish. No abstract available.

PMID:
3133861
38.

[Gliadin antibody titre as a diagnostic aid in celiac disease].

Friis SU, Jarnum S.

Ugeskr Laeger. 1988 Apr 4;150(14):845-7. Danish. No abstract available.

PMID:
3363715
39.

Chronic intestinal pseudo-obstruction in patients with extensive bowel resection for Crohn's disease.

Myrhøj T, Ladefoged K, Jarnum S.

Scand J Gastroenterol. 1988 Apr;23(3):380-4.

PMID:
3387904
40.

Calcium-binding protein in human duodenal biopsies.

Staun M, Boesby S, Daugaard H, Jarnum S.

Calcif Tissue Int. 1988 Apr;42(4):205-9.

PMID:
3135085
41.

Faecal osmolality and electrolyte concentrations in chronic diarrhoea: do they provide diagnostic clues?

Ladefoged K, Schaffalitzky de Muckadell OB, Jarnum S.

Scand J Gastroenterol. 1987 Sep;22(7):813-20.

PMID:
3672039
42.
43.

Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome.

Jacobsen O, Ladefoged K, Stage JG, Jarnum S.

Scand J Gastroenterol. 1986 Sep;21(7):824-8.

PMID:
3095911
44.

Catheter-related septicaemia in patients receiving home parenteral nutrition.

Rannem T, Ladefoged K, Tvede M, Lorentzen JE, Jarnum S.

Scand J Gastroenterol. 1986 May;21(4):455-60.

PMID:
3088720
45.

[Radical surgery in ulcerative colitis with preservation of anal sphincter function. Preliminary results with a J-formed ileal reservoir].

Kirkegaard P, Bülow S, Jarnum S, Stadil F.

Ugeskr Laeger. 1986 Jan 13;148(3):124-7. Danish. No abstract available.

PMID:
3952834
46.

Malignancy in Crohn's disease.

Kvist N, Jacobsen O, Nørgaard P, Ockelmann HH, Kvist HK, Schou G, Jarnum S.

Scand J Gastroenterol. 1986 Jan;21(1):82-6.

PMID:
3952455
47.

[Defined formula diet in the treatment of active Crohn disease].

Malchow H, Lorenz-Meyer H, Steinhardt HJ, Strohm WD, Rasmussen S, Sommer H, Jarnum S, Brandes JW, Leonhardt H, Ewe K, et al.

Beitr Infusionther Klin Ernahr. 1986;14:216-31. German. No abstract available.

PMID:
2877655
48.

Effect of enterocoated cholestyramine on bowel habit after ileal resection: a double blind crossover study.

Jacobsen O, Højgaard L, Hylander Møller E, Wielandt TO, Thale M, Jarnum S, Krag E.

Br Med J (Clin Res Ed). 1985 May 4;290(6478):1315-8.

49.

Non-tropical sprue. Malignant diseases and mortality rate.

Nielsen OH, Jacobsen O, Pedersen ER, Rasmussen SN, Petri M, Laulund S, Jarnum S.

Scand J Gastroenterol. 1985 Jan;20(1):13-8.

PMID:
3992161
50.

Metabolic complications to total parenteral nutrition.

Ladefoged K, Jarnum S.

Acta Anaesthesiol Scand Suppl. 1985;82:89-94. Review. No abstract available.

PMID:
3933270

Supplemental Content

Loading ...
Support Center